EUVIMEDEUVIMED entdecken
Crossref

Advancing Targeted Drug Delivery in Glioblastoma Multiforme Through Biomimetic Nanomedicine Using 3D Tumor‐On‐a‐Chip Model

Twinkle Jina Minette Manoharan, Ting-Yun Wang, Shivani Mantri, Hanan Alarnous, Shwetal Mehta, Kuei-Chun Wang, Mehdi Nikkhah iD

Advanced Healthcare Materials · 2026-01 · 15 (4)

DOI: 10.1002/adhm.202502454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 08.09.2025. Verfasst von Twinkle Jina Minette Manoharan und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological and Health Systems Engineering (SBHSE), Arizona State University, Tempe, AZ, 85287, USA. Hauptthemen laut MEDLINE: Glioblastoma, Lab-On-A-Chip Devices, Drug Delivery Systems, Nanomedicine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: NIH HHS, National Science Foundation, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prognosis of glioblastoma multiforme (GBM) remains dismal, despite standard treatment regimens. A key challenge in treating GBM is the persistence of glioma stem cells (GSCs) within the perivascular niche (PVN) – a protective tumor microenvironment (TME) that is often associated with inadequate drug penetration. Current preclinical models do not capture complexity of the human TME, particularly the vasculature and niche‐specific interactions that drive GBM progression. To overcome these limitations, an innovative 3D ex‐vivo tumor‐on‐a‐chip (TOC) platform is engineered to accurately replicate the structural and functional characteristics of the PVN. Using this platform, this study demonstrates that monocyte membrane‐coated nanoparticles (MoNP) effectively target the abnormal tumor microvasculature, offering a promising approach to enhance drug delivery to these hard‐to‐reach GSCs. The results show that the therapeutic agent verteporfin, when delivered via MoNP, significantly inhibited GSC growth and invasiveness, while the free‐form drug showed minimal efficacy. Comprehensive transcriptomic profiling and cytokine analysis validated the TOC model's ability to reflect authentic GSC responses and confirmed that MoNP‐mediated verteporfin delivery effectively modulates key tumor‐related signaling pathways. This integrated TOC‐MoNP platform represents a clinically relevant tool that bridges the gap between traditional preclinical models and human disease, providing new opportunities for developing more effective GBM therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaLab-On-A-Chip DevicesDrug Delivery SystemsNanomedicineBrain NeoplasmsBiomimetic MaterialsHumansTumor MicroenvironmentCell Line, TumorNanoparticlesVerteporfinNeoplastic Stem CellsBiomimeticsAntineoplastic Agents

Stichwörter der Autor:innen

glioblastoma multiforme (GBM)microfluidicsnanomedicinetargeted deliverytumor‐on‐a‐chip

Substanzen

VerteporfinAntineoplastic Agents

Autor:innen und Institutionen

  • School of Biological and Health Systems Engineering (SBHSE), Arizona State University, Tempe, AZ, 85287, USA.
  • School for Engineering of Matter, Transport and Energy (SEMTE), Arizona State University, Tempe, AZ, 85287, USA.
  • Ivy Brain Tumor Center, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, 85013, USA.
  • Biodesign Virginia G. Piper Center for Personalized Diagnostics, Arizona State University, Tempe, AZ, 85287, USA.

ORCID-Profile: Mehdi Nikkhah

Förderung

  • NIH HHS
  • National Science Foundation
  • NINDS NIH HHS
  • Arizona Biomedical Research Centre
  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Manoharan, T. J. M., Wang, T. Y., Mantri, S., Alarnous, H., Mehta, S., Wang, K. C., & Nikkhah, M. (2026). Advancing Targeted Drug Delivery in Glioblastoma Multiforme Through Biomimetic Nanomedicine Using 3D Tumor‐On‐a‐Chip Model. Advanced Healthcare Materials, 15(4). https://doi.org/10.1002/adhm.202502454

Vancouver

Manoharan TJM, Wang TY, Mantri S, Alarnous H, Mehta S, Wang KC, et al. Advancing Targeted Drug Delivery in Glioblastoma Multiforme Through Biomimetic Nanomedicine Using 3D Tumor‐On‐a‐Chip Model. Advanced Healthcare Materials. 2026;15(4). doi:10.1002/adhm.202502454

BibTeX
@article{Manoharan2026,
  author = {Manoharan, Twinkle Jina Minette and Wang, Ting-Yun and Mantri, Shivani and Alarnous, Hanan and Mehta, Shwetal and Wang, Kuei-Chun and Nikkhah, Mehdi},
  title = {Advancing Targeted Drug Delivery in Glioblastoma Multiforme Through Biomimetic Nanomedicine Using 3D Tumor‐On‐a‐Chip Model},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {4},
  doi = {10.1002/adhm.202502454}
}
Kostenlos starten →